Connecting you to content on EBSCOhost

Works matching IS 11732563 AND DT 2025 AND VI 45 AND IP 1

Results: 5

1

Optimizing Individualized Antimicrobial Dosing in Pediatric Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Therapeutic Drug Monitoring and Experimental Doses: N. Yalçın et al.

Published in:

2025

By:

Yalçın, Nadir;
Dirik, Yağmur;
Bayraktar, İzgi;
Umaroğlu, Mutlu;
Allegaert, Karel

Publication type:

Literature Review

2

Authors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database": Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors: T. Sakamoto et al

Published in:

Clinical Drug Investigation, 2025, v. 45, n. 1, p. 47, doi. 10.1007/s40261-024-01414-7

By:

Sakamoto, Toshiaki;
Miyamoto, Hirotaka;
Hashizume, Junya;
Akamatsu, Hayato;
Akagi, Tomoaki;
Kodama, Yukinobu;
Hamano, Hirofumi;
Zamami, Yoshito;
Ohyama, Kaname

Publication type:

Article

3

Phenotypes of Patients with Direct Oral Anticoagulant (DOAC) Underdosing in Atrial Fibrillation: Results from the ARENA Registry: Phenotypes of Patients with Direct Oral Anticoagulant (DOAC) Underdosing in Atrial Fibrillation: C. Brockmüller et al

Published in:

Clinical Drug Investigation, 2025, v. 45, n. 1, p. 29, doi. 10.1007/s40261-024-01411-w

By:

Brockmüller, Christine;
Meid, Andreas D.;
Senges, Jochen;
Hochadel, Matthias;
Haefeli, Walter E.;
Stoll, Felicitas

Publication type:

Article

4

Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study: NUN-004 in Patients with Amyotrophic Lateral Sclerosis: M. Gerometta et al

Published in:

Clinical Drug Investigation, 2025, v. 45, n. 1, p. 17, doi. 10.1007/s40261-024-01410-x

By:

Gerometta, Michael;
Henderson, Robert D.;
Friend, Richard;
Cooper, Leanne T.;
Zhao, Jing;
Boyd, Andrew W.;
Bartlett, Perry F.

Publication type:

Article

5

Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database.": AEs of SGLT2 Inhibitors in DM or Heart Failure: Y. Noguchi et al

Published in:

Clinical Drug Investigation, 2025, v. 45, n. 1, p. 45, doi. 10.1007/s40261-024-01407-6

By:

Noguchi, Yoshihiro;
Suzuki, Keiko;
Ino, Yoko;
Yoshimura, Tomoaki

Publication type:

Article